Protagen Collaborating With UCSF on Prostate Cancer Immunotherapy Work – 360Dx
|
Protagen Collaborating With UCSF on Prostate Cancer Immunotherapy Work
360Dx NEW YORK (360Dx) – Protagen said today it has entered a collaboration with the University of California, San Francisco to use the company's SeroTag platform for research into immunotherapies for prostate cancer. The collaboration will use Protagen's … Protagen AG Collaborates with UCSF to Study Better Immuno-Profiling of Cancer Patients Receiving Immunotherapy |
